×

Register now for full access to all the content

First Name
Last Name
Company Name
Title
Country
Thank you for registering!
Error - something went wrong!

Payer insights for cell and gene therapies

February 5, 2021

It is essential to address the payer landscape very early in development for a product administered once with a lifelong effect, such as a gene therapy. The one-time, front-loaded costs of these treatments have necessitated new payment models to win payer approval and be affordable. In this short video, Emma Medin, VP, Pricing & Market Access, shares three payer insights to help you price appropriately for your cell or gene therapy. Get more insights from our experts by visiting https://www.parexel.com/neverstop.

Previous Article
101 guide for real-world evidence
101 guide for real-world evidence

Next Video
Maximizing your virtual investigator meeting results
Maximizing your virtual investigator meeting results

Learn how Parexel brings the principles and energy from face-to-face investigator meetings to an interactiv...